Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery
PHASE2CompletedINTERVENTIONAL
Enrollment
256
Participants
Timeline
Start Date
December 31, 2014
Primary Completion Date
September 30, 2015
Study Completion Date
September 30, 2015
Conditions
InflammationPainCataract
Interventions
DRUG
RX-10045
topical therapy
Trial Locations (1)
07974
Auven Therapeutics, Murray Hill
All Listed Sponsors
lead
A.T. Resolve SARL
INDUSTRY
NCT02329743 - Efficacy and Safety of RX-10045 Ophthalmic Solution for Ocular Inflammation and Pain in Cataract Surgery | Biotech Hunter | Biotech Hunter